If you are growing a biotech team in San Francisco, Mission Bay can look like the obvious answer. It offers a rare mix of UCSF adjacency, transit access, and a built environment that was planned with office, lab, and R&D uses in mind. But lab space is not just office space with benches, and the wrong lease can create expensive surprises. This guide walks you through the basics so you can evaluate Mission Bay space more clearly and make better decisions early.
Why Mission Bay matters for biotech
Mission Bay is not an accidental life science cluster. According to the San Francisco Office of Community Investment and Infrastructure, the neighborhood spans 303 acres and was planned as a mixed-use, transit-oriented redevelopment area, with Mission Bay South serving as the city’s office, biotech, and institutional core.
That planning matters when you are searching for lab space. Mission Bay South’s commercial framework specifically identifies office, laboratory, and R&D uses, including life science and technology campuses on Blocks 41 through 43. At full build-out, the area is planned for up to 4.4 million square feet of private commercial space alongside a 43-acre UCSF research campus and medical center.
For many growing teams, the appeal is straightforward. You get an in-city location with strong research adjacency and transit connectivity, which can be hard to replicate in suburban alternatives.
Mission Bay in the Bay Area market
Mission Bay sits inside a much larger regional life science ecosystem. CBRE reports that the Bay Area has 51.3 million square feet of life sciences inventory, more than 147,000 industry workers, over 42,000 R&D roles, and more than $51 billion in venture funding between 2019 and 2024.
Even so, Mission Bay fills a specific niche. Nearby Peninsula options in Redwood City, Millbrae, and South San Francisco often offer larger projects, but they can also be heavily preleased. That makes Mission Bay especially relevant if your team values a San Francisco address, proximity to UCSF, and transit access more than maximum contiguous space.
Current market data shows there is still activity here. In Q4 2025, San Francisco County had 3.65 million square feet of life sciences inventory, 13.2% vacancy, and average asking rent of $6.96 per square foot per month on an NNN basis, with no square feet under construction. The same quarter also included a 62,250-square-foot new lease at 1800 Owens Street, which signals continued tenant demand in the submarket.
Why lab space is different from office
One of the biggest mistakes growing biotech companies make is treating lab space like a standard office search. The technical requirements are very different, and those differences affect speed, cost, and risk.
Stanford’s laboratory design guidance highlights several basics that matter from day one. Purpose-built lab space should separate office and lab zones, provide safe hazardous-material storage, include spill control and secondary containment, and support continuous ventilation.
Ventilation is especially important. General labs using hazardous materials need continuous exhaust ventilation, and inadequate systems can lead to costly retrofits later. In practical terms, that means a space that looks usable on a tour may still fall short once your engineers and consultants review the building systems.
What to look for in a Mission Bay lab shell
When you tour space, focus less on finishes and more on infrastructure. A marginal office-to-lab conversion may work, but only if the building already aligns closely with your operating model.
Start with these questions:
- Does the space have the power capacity your equipment requires?
- Can the building support your cooling and ventilation needs?
- Is there appropriate loading access for deliveries and operations?
- Is there suitable storage for materials and supplies?
- Are office and lab functions easy to separate within the layout?
These points matter because fit-out costs are high. Cushman & Wakefield’s 2026 fit-out guide places average life sciences fit-out cost at $741 per square foot. That number alone explains why the base building matters so much.
The real cost is not just rent
Rent is only one part of your occupancy cost. In Mission Bay, the bigger financial story often comes from build-out, concessions, and operating expense pass-throughs.
For reference, San Francisco County’s Q4 2025 asking rent for life sciences space was $6.96 per square foot per month NNN. In an NNN lease, landlords typically pass most operating expenses through to tenants, so your monthly cost can rise beyond base rent.
That structure deserves careful review in lab buildings. Specialized mechanical systems and safety systems are more central to operations than they are in a typical office property, which can make CAM and operating expenses feel heavier.
How tenant improvements work in life science leases
Tenant improvement packages can help, but they rarely cover the full cost of a sophisticated lab build-out. Cushman & Wakefield reports that Bay Area TI packages average $200 to $250 per square foot.
That sounds substantial until you compare it with the average fit-out cost of $741 per square foot. In many cases, you should expect either meaningful out-of-pocket capital spending or a heavily negotiated turnkey package.
This is one reason landlords often respond best to tenants that present a clear technical scope. If you can explain your program, timing, and infrastructure needs early, you are in a better position to negotiate around cost and delivery.
Why lease term matters for growing teams
Flexibility can be valuable when your headcount and funding path are still changing. Current life science leasing trends suggest that smaller deals often come with shorter terms.
Cushman & Wakefield found that average lease term fell from 83 months in 2021 to 69 months in Q1 2025 overall. Leases at or below 50,000 square feet averaged 61 months, while larger deals averaged 125 months.
For a growing biotech company, that gap matters. If your requirement is modest today but could change quickly, a smaller footprint with a shorter term may align better with your risk profile than a larger long-term commitment.
What landlords want in this market
Landlords are paying close attention to execution risk. In the current market, they are generally more likely to reward credit quality, certainty, and a well-defined technical scope than to speculate on expensive shell-to-lab conversions.
That makes preparation important on the tenant side. You do not need every answer on day one, but you should be ready to explain your use, your likely equipment profile, your target timing, and how much build-out support you expect.
Concessions remain common in the broader market. Free rent, AV and IT allowances, and turnkey build-outs have become more standard in the U.S. life sciences market, but each deal still depends on the building, the landlord, and the complexity of your requirements.
Mission Bay approvals can be layered
Mission Bay is curated, but that also means it is not a simple plug-and-play district. Development in the area is governed through redevelopment plans, Design for Development documents, owner participation agreements, and interagency cooperation agreements.
According to OCII, the Mission Bay South framework can supersede the Planning Code except where it says otherwise. Development review also follows district-specific design review and document approval procedures, along with adopted mitigation measures and city engineering and transportation requirements.
For tenants, the takeaway is simple. You should confirm early whether your proposed scope triggers parcel-level or district-level review issues that could affect timing.
Regulatory questions to raise early
If your planned use involves hazardous materials or emissions-producing equipment, the regulatory path becomes even more important. Early diligence can help you avoid delays after lease signing.
Here are some key questions to ask at the start:
- What building systems are already installed in the shell?
- What improvements still need permits or agency approvals?
- Will your planned equipment require air district permitting?
- What is included in CAM and operating-expense pass-throughs?
- Is there a cap on annual increases for controllable operating expenses?
- Does the parcel require OCII signoff for your planned scope?
Under California’s Hazardous Materials Business Plan program, businesses that handle hazardous materials must maintain an inventory, emergency procedures, employee training, and a site map. SF.gov also states that businesses handling hazardous materials or generating hazardous waste must register with the city.
Separately, the Bay Area Air Quality Management District says that nearly all stationary equipment that emits to the atmosphere requires an air district permit. Projects are reviewed for emissions and compliance before an Authority to Construct or Permit to Operate is issued.
A practical Mission Bay search strategy
If you are evaluating Mission Bay, it helps to think in stages rather than chasing every available listing. The best process usually starts with operational clarity.
First, define your technical program. Know what equipment you expect to install, what ventilation you need, how your office and lab functions should be separated, and whether you will handle hazardous materials.
Next, match that program to building infrastructure. A space that saves time on power, cooling, ventilation, loading, and storage can be more valuable than a lower-rent option with major retrofit risk.
Then, underwrite the full occupancy cost. Review base rent, TI, free rent, expected capital spend, CAM structure, and any limits on operating-expense growth.
Finally, map the approval path early. In Mission Bay, layered district controls and technical permitting issues can influence move-in timing just as much as lease negotiations do.
The bottom line for growing biotech teams
Mission Bay remains one of the Bay Area’s most distinctive in-city lab submarkets. It combines planned life science infrastructure, UCSF adjacency, and transit access in a way that appeals to companies that want an urban research setting.
At the same time, success here depends on understanding what really drives cost and timing. The biggest issues are usually not just face rent. They are the quality of the shell, the scope of the build-out, the structure of operating-cost pass-throughs, and the approvals tied to your specific use.
If you approach the search with a clear technical brief and a disciplined lease review process, you can compare Mission Bay options much more effectively and avoid expensive surprises later. If you need a partner to help you evaluate occupancy costs, build-out implications, and lease strategy, connect with Tide Realty Group.
FAQs
What makes Mission Bay lab space different from regular office space?
- Mission Bay lab space often needs specialized infrastructure such as continuous ventilation, hazardous-material storage, spill control, stronger building systems, and layouts that separate office and lab functions.
What should a growing biotech team review before leasing Mission Bay lab space?
- You should review building power, cooling, ventilation, loading, storage, tenant improvement support, CAM pass-throughs, possible operating-expense caps, and any approvals or permits required for your planned use.
What are asking rents for life sciences space in San Francisco County?
- In Q4 2025, asking rent for San Francisco County life sciences space was reported at $6.96 per square foot per month on an NNN basis.
What are typical lab build-out costs for biotech space?
- Cushman & Wakefield’s 2026 guide lists average life sciences fit-out cost at $741 per square foot, which is why the condition of the base building is so important.
What permits may apply to a Mission Bay biotech lab build-out?
- Depending on your use, you may need hazardous materials compliance steps under California and San Francisco requirements, and emissions-related equipment may require Bay Area Air Quality Management District permitting before installation or operation.
Why do smaller biotech tenants often seek shorter lease terms?
- Smaller life sciences deals tend to have shorter average terms, which can help growing teams manage uncertainty around headcount, funding, and future space needs.
